Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

KVENTIAX™ SR prolonged-release tablets 400mg, 60pcs

🔥 8 items sold in last 3 hours
4 people are viewing this product
Active Ingredient:

Manufacturer:

$146.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

ABISIL™ oily solution 20% (15ml), 1pc

$54.00
Add to cart

9 MONTHS™ FOLIC ACID tablets 400mcg, 30pcs

$10.00
Add to cart

Analogs of KVENTIAX™ SR

QUENTIAX™ SR prolonged-release tablets 300mg, 60pcs

$132.00
Add to cart

KVENTIAX™ tablets 100mg, 60pcs

$69.00
Add to cart

KVENTIAX™ tablets 200mg, 60pcs

$114.00
Add to cart

KVENTIAX™ tablets 25mg, 60pcs

$35.00
Add to cart

Table of Contents

KVENTIAX™ SR 400mg Tablets Buy Online

Kventiax SR: A Comprehensive Overview

Managing mental health conditions requires a multifaceted approach, and sometimes, medication plays a crucial role. Kventiax SR, with its unique formulation, offers a potential solution for certain individuals. This comprehensive overview explores its uses, mechanisms, and important considerations.

Understanding Kventiax SR

What is Kventiax SR?

Kventiax SR is a medication containing quetiapine, an atypical antipsychotic. The “SR” denotes its prolonged-release formulation, meaning the medication is released gradually into the bloodstream over an extended period. This design aims to provide a more consistent therapeutic effect throughout the day, potentially reducing the fluctuation of drug levels seen with immediate-release formulations. Understanding this controlled release is key to comprehending its efficacy and potential side effects.

Mechanism of Action

Quetiapine’s precise mechanism isn’t fully understood, but it’s believed to involve interactions with multiple neurotransmitter receptors in the brain. Specifically, it’s known to bind to serotonin and dopamine receptors, influencing the balance of these crucial neurochemicals. This complex interaction is thought to contribute to its effectiveness in treating a variety of conditions. The prolonged-release aspect ensures a more stable interaction with these receptors over time, contributing to its therapeutic profile. Further research continues to unravel the complexities of its action.

What is Kventiax SR?

Kventiax SR is an atypical antipsychotic medication containing quetiapine fumarate. It’s specifically formulated as a prolonged-release tablet, designed to deliver a consistent level of the active ingredient over a longer duration compared to immediate-release versions. This sustained release is intended to improve treatment efficacy and reduce the risk of significant fluctuations in blood levels of quetiapine. The 400mg strength, as indicated by the product description, represents a common dosage for certain treatment regimens.

This formulation, therefore, distinguishes itself from standard quetiapine by providing a more even therapeutic effect. This controlled release mechanism is a key feature that sets Kventiax SR apart and influences its usage and potential benefits. The extended release characteristic should be considered when understanding the drug’s overall impact on the patient.

Mechanism of Action

Quetiapine, the active ingredient in Kventiax SR, exerts its effects through a complex interaction with various neurotransmitter receptors in the brain. While the precise mechanism isn’t fully elucidated, its affinity for both serotonin (5-HT2) and dopamine (D1 and D2) receptors is a key aspect of its action. This dual action distinguishes it from some older antipsychotics, which primarily target dopamine receptors. The modulation of these neurotransmitters is believed to contribute to its therapeutic benefits in specific mental health conditions.

The prolonged-release formulation ensures a more gradual and sustained release of quetiapine into the bloodstream. This controlled release is hypothesized to lead to a more stable therapeutic effect, minimizing the peaks and troughs in plasma concentrations often associated with immediate-release formulations. This consistent level of the drug in the body may contribute to improved efficacy and a reduced risk of certain side effects. Further research is ongoing to fully understand the long-term implications of this sustained-release approach.

Uses and Indications

Approved Conditions

Kventiax SR’s primary applications lie in the management of specific mental health conditions. It’s frequently prescribed for the treatment of schizophrenia, a chronic mental illness characterized by a range of symptoms including hallucinations, delusions, and disorganized thinking. The sustained release of quetiapine in Kventiax SR may offer advantages in managing the unpredictable nature of this disorder. Effective management often requires a long-term approach, and consistent medication levels are crucial.

Specific Applications

Beyond schizophrenia, Kventiax SR may also be used to treat bipolar disorder, a condition marked by extreme shifts in mood between manic highs and depressive lows. Its ability to manage both manic and depressive episodes makes it a valuable tool in this context. In bipolar disorder, maintaining mood stability is paramount, and the prolonged-release properties of Kventiax SR aim to support this goal. The precise use and dosage will depend on individual patient needs and response to treatment, as determined by a healthcare professional.

Approved Conditions

Kventiax SR, containing quetiapine fumarate, holds approval for treating several significant mental health conditions. Its primary use is in managing the symptoms of schizophrenia, a chronic and debilitating illness affecting millions worldwide. This approval highlights its role in addressing the core symptoms of schizophrenia, including hallucinations, delusions, and disorganized thinking, offering patients a potential path toward improved mental well-being and better quality of life.

Furthermore, Kventiax SR is also approved for the treatment of bipolar I disorder, specifically targeting both the manic and depressive phases of the illness. This broad application underscores its versatility in managing the fluctuating mood extremes characteristic of this complex condition. The drug’s ability to address both poles of the bipolar spectrum makes it a valuable treatment option for many patients. Careful monitoring and dose adjustments are often necessary to optimize treatment efficacy and minimize potential side effects.

Specific Applications

While primarily used for schizophrenia and bipolar I disorder, Kventiax SR’s applications can extend to other contexts under specific circumstances and always under the guidance of a healthcare professional. For instance, it might be considered as part of a treatment plan for acute manic episodes within bipolar disorder, helping to stabilize mood and reduce the intensity of symptoms. The decision to use Kventiax SR in this way would be made on a case-by-case basis, carefully considering the patient’s individual needs and overall health status.

Furthermore, Kventiax SR may play a role in the prevention of relapse in individuals with stable schizophrenia or bipolar disorder. By maintaining consistent levels of quetiapine, the medication aims to reduce the likelihood of symptom recurrence and promote long-term mental stability. This preventative aspect is a crucial consideration in managing chronic mental illness, allowing patients to live more fulfilling lives with less disruption from their condition. The precise approach to relapse prevention is tailored to each individual’s history and response to treatment.

Dosage and Administration

Recommended Dosage

Dosage regimens for Kventiax SR are highly individualized and determined by a healthcare professional based on the specific condition being treated, the patient’s response, and other relevant factors. It’s crucial to emphasize that self-adjusting dosages is dangerous and should never be attempted. Starting dosages are typically lower, with gradual increases as tolerated to reach the optimal therapeutic level while minimizing side effects. The 400mg strength mentioned in the product description represents one possible dosage within a broader range of options.

Administration Guidelines

Kventiax SR tablets are designed for oral administration. They should be swallowed whole, and it’s essential to avoid crushing, breaking, or chewing the tablets. This is because the prolonged-release formulation relies on the integrity of the tablet to deliver the medication over time. Crushing or altering the tablet can disrupt this process, potentially leading to unpredictable drug levels and increased side effects. The medication is typically taken once daily, and the timing should be consistent as directed by a physician to maintain consistent therapeutic levels.

Recommended Dosage

Determining the appropriate dosage of Kventiax SR is a crucial step in its effective use, and it’s a process that should always be overseen by a qualified healthcare professional. There is no single “correct” dosage; instead, the amount prescribed will vary significantly depending on the individual patient, their specific condition (schizophrenia, bipolar disorder, etc.), the severity of their symptoms, and their overall health. Initial dosages are often lower, gradually increasing as needed under medical supervision. The 400mg strength represents one potential dosage point within a much wider range.

It’s vital to understand that adjusting the dosage independently is extremely risky and could have negative consequences. A healthcare provider will carefully monitor the patient’s response to the medication, making adjustments as necessary to optimize treatment while minimizing potential side effects. Regular check-ups and open communication with the prescribing physician are essential components of safe and effective Kventiax SR therapy. The goal is always to find the lowest effective dose to manage symptoms effectively.

Administration Guidelines

Kventiax SR tablets are intended for oral consumption and should be swallowed whole with liquid; never crush, chew, or break them. This is paramount because the prolonged-release formulation is designed to deliver quetiapine gradually over time. Compromising the tablet’s integrity can lead to an uneven release of the medication, potentially causing increased side effects or reduced therapeutic benefits. Consistency in both dosage and timing is also crucial for optimal results.

Generally, Kventiax SR is administered once daily, at the same time each day, as directed by the prescribing physician. This consistent scheduling helps maintain stable blood levels of quetiapine, contributing to a more predictable and effective therapeutic response. The specific time of day may vary depending on individual patient needs and tolerance. Adherence to the prescribed regimen is crucial for achieving the intended therapeutic outcomes and minimizing potential risks associated with inconsistent medication intake. Always follow your doctor’s instructions precisely.

Potential Benefits and Drawbacks

Like all medications, Kventiax SR offers potential benefits alongside potential drawbacks. It’s crucial to weigh these factors carefully, in consultation with a healthcare professional, to determine if it’s the right treatment choice for a particular individual. The decision to use any medication should always be a collaborative one, balancing potential advantages against potential risks. Individual responses to medication can vary considerably.

The potential benefits of Kventiax SR stem from its ability to effectively manage the symptoms of schizophrenia and bipolar disorder, thereby improving a patient’s quality of life. However, it’s essential to acknowledge that these benefits must be considered alongside the possibility of adverse effects. A thorough understanding of both the potential upsides and downsides is crucial for informed decision-making in the context of mental health treatment.

Pros

  • Improved Symptom Management: Kventiax SR’s prolonged-release formulation may lead to more consistent control of symptoms compared to immediate-release quetiapine, potentially reducing symptom fluctuations and enhancing overall therapeutic efficacy. This consistent delivery can be particularly beneficial for managing the unpredictable nature of conditions like schizophrenia and bipolar disorder.
  • Reduced Side Effects (Potential): The sustained release mechanism may contribute to a lower incidence or severity of certain side effects associated with quetiapine, although individual responses vary. This potential reduction in adverse effects can improve patient tolerability and adherence to the treatment regimen. However, it’s crucial to remember that side effects are still possible.
  • Once-Daily Dosing: The convenience of once-daily administration simplifies the medication routine, potentially improving adherence and reducing the burden of managing medication schedules. This ease of use can be a significant advantage for patients, particularly those who may struggle with complex medication regimens.

Cons

  • Potential for Side Effects: While the prolonged-release formulation may mitigate some side effects, others remain a possibility. These can include drowsiness, dizziness, weight gain, and metabolic changes. The severity and type of side effects vary greatly from person to person. Open communication with your doctor about any side effects experienced is crucial for appropriate management.
  • Individual Variability in Response: Responses to Kventiax SR can vary significantly between individuals. What works well for one person may not be as effective for another, and some patients may experience more pronounced side effects. Close monitoring by a healthcare professional is necessary to tailor treatment to individual needs and adjust the dosage accordingly.
  • Medication Interactions: As with many medications, Kventiax SR can interact with other drugs. It’s crucial to inform your doctor about all medications, supplements, and herbal remedies you are taking to minimize the risk of adverse interactions. This comprehensive disclosure helps prevent potentially harmful combinations and ensures safer use of the medication.

Summary

Precautions and Warnings

Important Considerations

Before starting Kventiax SR, it’s crucial to inform your doctor about any pre-existing medical conditions, particularly those affecting the liver or kidneys. Individuals with a history of seizures or a family history of seizures should exercise extra caution. The medication should be used with extreme care in patients with a history of glaucoma, prostate enlargement, or a tendency towards low blood pressure. This information is vital for your safety and optimal treatment.

Interactions

Kventiax SR can interact negatively with certain other medications, including some antidepressants and medications for other conditions. It is essential to provide a complete list of all medications, supplements, and herbal remedies you are taking to your doctor or pharmacist. These interactions can potentially alter the effectiveness of Kventiax SR or increase the risk of side effects. Failure to disclose such information can have serious consequences. Always keep your healthcare provider fully informed.

  • Kventiax™ Sr Prolonged-Release Tablets 400Mg, 60Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Kventiax™ Sr Prolonged-Release Tablets 400Mg, 60Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Kventiax™ Sr Prolonged-Release Tablets 400Mg, 60Pcs Buy Online 6
    [Medical reviewer]

    Dr. Elizabeth Dennis is a highly skilled Orthopedic Surgeon and consultant for RxPulsar.com, a licensed online pharmacy. She specializes in the management and surgical treatment of knee, shoulder, and...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “KVENTIAX™ SR prolonged-release tablets 400mg, 60pcs”

Your email address will not be published. Required fields are marked

Similar products

METADOXIL™ tablets 500mg, 10pcs

$68.00
Add to cart

MEXIV 6™ tablets 125mg+10mg, 30pcs

$25.00
Add to cart

KOMPLIGAM B™ solution for intramuscular injection 2ml, 10pcs

$26.00
Add to cart

KOMPLIGAM B™ solution for intramuscular injection 2ml, 5pcs

$17.00
Add to cart

COMBILIPEN™ solution for i.m. injection 2ml, ampoules 10pcs

$25.00
Add to cart

COMBILIPEN™ solution for i.m. injection 2ml, ampoules 5pcs

$19.00
Add to cart

COMBILIPEN™ TABS tablets 30pcs

$25.00
Add to cart

COMBILIPEN™ TABS tablets, 60pcs

$39.00
Add to cart

KVENTIAX™ tablets 200mg, 60pcs

$114.00
Add to cart

KALMIREX™ solution for intramuscular injection 100mg/ml+2.5mg/ml (1ml), 5pcs

$36.00
Add to cart

CAVINTON™ concentrate for infusion solution 5mg/ml (2ml), 10pcs

$18.00
Add to cart

IPIGRIX™ solution for intramuscular and subcutaneous injection 15mg/ml (1ml), 10pcs

$216.00
Add to cart

IPIGRIX™ solution for intramuscular and subcutaneous injection 5mg/ml (1ml), 10 ampoules

$141.00
Add to cart

IPIDACRINE VELFARM™ solution for intramuscular and subcutaneous injection 15mg/ml (1ml), 10pcs

$78.00
Add to cart

IPIDACRINE VELFARM™ solution for intramuscular and subcutaneous injection 5mg/ml (1ml), 10pcs

$48.00
Add to cart

IPIDACRINE-SZ™ tablets 20mg, 100pcs

$83.00
Add to cart

DIVAZA™ orodispersible tablets, 100pcs

$40.00
Add to cart

GOPANTAM™ tablets 500mg, 50pcs

$35.00
Add to cart

GLYCINE sublingual tablets 100mg, 50pcs

$5.00
Add to cart

GALANTAMINE CANON™ tablets 12mg, 56pcs

$222.00
Add to cart

HALOPERIDOL tablets 1.5mg, 50pcs

$6.00
Add to cart

BACLOSAN™ tablets 10mg, 50pcs

$20.00
Add to cart

AXAMON™ solution for i.m. and s.c. injection 15mg/ml (1ml), 10pcs

$143.00
Add to cart

AXAMON™ tablets 20mg, 50pcs

$86.00
Add to cart
Select your currency